Quoteworthy: "It’s not a matter of yes or no — it’s a matter of how much I can get." –— Paul Schulte of equity research firm Schulte Research, referring to appetite among investors for Ant Group’s hotly-anticipated US$35 billion ($47 billion) IPO.

South Korean deaths spark flu vaccine safety fears

South Korean officials refused to suspend the country’s seasonal flu inoculation programme on Oct 22, despite growing calls to do so following the deaths of at least 13 people who were vaccinated in recent days.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook